Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018

J Rheumatol. 2019 Oct;46(10):1355-1359. doi: 10.3899/jrheum.181099. Epub 2019 Apr 1.

Abstract

Objective: Establishing a research agenda on standardizing pain measurement in clinical trials in rheumatic and musculoskeletal diseases (RMD).

Methods: Discussion during a meeting at the Outcome Measures in Rheumatology (OMERACT) 2018, prepared by a systematic review of existing core outcome sets and a patient online survey.

Results: Several key questions were debated: Is pain a symptom or a disease? Are pain core (sub)domains consistent across RMD? How to account for pain mechanistic descriptors (e.g., central sensitization) in pain measurement?

Conclusion: Characterizing and assessing the spectrum of pain experience across RMD in a standardized fashion is the objective of the OMERACT Pain Working Group.

Keywords: MEASUREMENT; MUSCULOSKELETAL HEALTH; OMERACT; PAIN; RHEUMATOLOGY.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Chronic Pain / diagnosis*
  • Consensus
  • Health Surveys
  • Humans
  • Musculoskeletal Diseases / physiopathology*
  • Outcome Assessment, Health Care / methods*
  • Pain Measurement / methods*
  • Public Opinion
  • Quality of Life
  • Rheumatic Diseases / physiopathology*
  • Rheumatology / methods